A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Mckesson Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 246,237 shares of MCK stock, worth $153 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
246,237
Previous 257,265 4.29%
Holding current value
$153 Million
Previous $150 Million 19.01%
% of portfolio
0.7%
Previous 0.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$479.06 - $630.38 $5.28 Million - $6.95 Million
-11,028 Reduced 4.29%
246,237 $122 Million
Q2 2024

Aug 14, 2024

SELL
$518.81 - $607.81 $28.1 Million - $32.9 Million
-54,189 Reduced 17.4%
257,265 $150 Million
Q1 2024

May 14, 2024

SELL
$473.42 - $539.26 $11.3 Million - $12.8 Million
-23,811 Reduced 7.1%
311,454 $167 Million
Q4 2023

Feb 14, 2024

BUY
$437.42 - $470.64 $2.87 Million - $3.08 Million
6,553 Added 1.99%
335,265 $155 Million
Q3 2023

Nov 13, 2023

BUY
$402.4 - $446.42 $14.6 Million - $16.1 Million
36,169 Added 12.36%
328,712 $143 Million
Q2 2023

Aug 11, 2023

BUY
$354.01 - $427.31 $4.56 Million - $5.5 Million
12,878 Added 4.6%
292,543 $125 Million
Q1 2023

May 12, 2023

SELL
$335.35 - $386.06 $2.63 Million - $3.02 Million
-7,834 Reduced 2.72%
279,665 $99.6 Million
Q4 2022

Feb 13, 2023

BUY
$346.68 - $397.58 $6 Million - $6.89 Million
17,318 Added 6.41%
287,499 $108 Million
Q3 2022

Nov 10, 2022

SELL
$321.25 - $373.84 $4.74 Million - $5.51 Million
-14,746 Reduced 5.18%
270,181 $91.8 Million
Q2 2022

Aug 11, 2022

BUY
$300.57 - $336.42 $8.49 Million - $9.5 Million
28,238 Added 11.0%
284,927 $92.9 Million
Q1 2022

May 13, 2022

BUY
$244.61 - $310.48 $19 Million - $24.1 Million
77,553 Added 43.29%
256,689 $78.6 Million
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $4.14 Million - $5.19 Million
20,864 Added 13.18%
179,136 $44.5 Million
Q3 2021

Nov 12, 2021

BUY
$188.42 - $208.66 $4.51 Million - $4.99 Million
23,934 Added 17.82%
158,272 $31.6 Million
Q2 2021

Aug 13, 2021

BUY
$184.89 - $202.68 $13.8 Million - $15.1 Million
74,547 Added 124.68%
134,338 $25.7 Million
Q1 2021

May 14, 2021

SELL
$169.52 - $196.53 $758,432 - $879,275
-4,474 Reduced 6.96%
59,791 $11.7 Million
Q4 2020

Feb 12, 2021

BUY
$143.79 - $183.66 $3.52 Million - $4.49 Million
24,460 Added 61.45%
64,265 $11.2 Million
Q3 2020

Nov 13, 2020

BUY
$140.89 - $159.9 $5.09 Million - $5.78 Million
36,150 Added 989.06%
39,805 $5.93 Million
Q2 2020

Aug 12, 2020

SELL
$125.49 - $164.68 $408,469 - $536,033
-3,255 Reduced 47.11%
3,655 $561,000
Q1 2020

May 14, 2020

BUY
$115.75 - $170.96 $799,832 - $1.18 Million
6,910 New
6,910 $935,000
Q4 2019

Feb 13, 2020

SELL
$130.23 - $153.27 $22 Million - $25.8 Million
-168,575 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$134.24 - $148.53 $5.9 Million - $6.52 Million
43,917 Added 35.23%
168,575 $23 Million
Q2 2019

Aug 13, 2019

SELL
$112.47 - $134.93 $3.64 Million - $4.36 Million
-32,337 Reduced 20.6%
124,658 $16.8 Million
Q1 2019

May 14, 2019

BUY
$111.86 - $136.3 $7.43 Million - $9.05 Million
66,378 Added 73.25%
156,995 $18.4 Million
Q4 2018

Feb 13, 2019

BUY
$108.23 - $136.84 $6.27 Million - $7.92 Million
57,901 Added 176.98%
90,617 $10 Million
Q3 2018

Nov 13, 2018

SELL
$123.14 - $138.52 $2.96 Million - $3.33 Million
-24,036 Reduced 42.35%
32,716 $4.34 Million
Q2 2018

Aug 13, 2018

BUY
$133.4 - $158.13 $6.87 Million - $8.14 Million
51,501 Added 980.78%
56,752 $0
Q1 2018

May 15, 2018

SELL
$138.75 - $176.72 $5.95 Million - $7.58 Million
-42,902 Reduced 89.1%
5,251 $740,000
Q4 2017

Feb 13, 2018

BUY
$135.02 - $162.6 $1.86 Million - $2.25 Million
13,807 Added 40.2%
48,153 $7.51 Million
Q3 2017

Nov 13, 2017

BUY
$146.0 - $161.87 $5.01 Million - $5.56 Million
34,346
34,346 $5.28 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.